Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$23.69 USD
-0.40 (-1.64%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $23.68 -0.01 (-0.04%) 6:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Viking Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
VKTX 23.69 -0.40(-1.64%)
Will VKTX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VKTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VKTX
AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?
Will Rybelsus' Updated EU Label Propel Fresh Growth Potential for NVO?
VKTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now?
Where Does VKTX Stock Stand After the Obesity Pill Setback?
Other News for VKTX
VKTX forms Stochastic Reached Oversold on September 15
VKTX's price falls by 3.61% on September 12, though its technical setup remains stable.
The GLP-1 Oral Frontier: Novo Nordisk And Eli Lilly's 100-Year Duel Enters Its Next Chapter
SA Asks: Which biotechs could be acquired by year's end?
Is VKTX building bearish momentum? 180 Bearish Setup shows up after declining 0.5%